Treatment of persistent phenothiazine-induced oral dyskinesia.
D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced* / Q000188:drug therapy; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D009912:Oral Manifestations; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects*; D010879:Piperazines / Q000008:administration & dosage; D010919:Placebos; D014149:Tranquilizing Agents / Q000008:administration & dosage*
D010640:Phenothiazines; D010879:Piperazines; D010919:Placebos; D014149:Tranquilizing Agents